The Development of Rational Strategies for Selective Immunotherapy against Autoimmune Demyelinating Disease (Q36665881)

15 August 2017

1 reference

title

The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease (English)

1 reference

15 August 2017

The Development of Rational Strategies for Selective Immunotherapy against Autoimmune Demyelinating Disease (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

5 November 2022

1 reference

1

L. Steinman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1713016

5 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1713016

5 November 2022

publication date

1 January 1991

1 reference

15 August 2017

Advances in Immunology

1 reference

15 August 2017

49

1 reference

15 August 2017

357-379

1 reference

T cell receptors in murine autoimmune diseases

15 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

The T lymphocyte in experimental allergic encephalomyelitis

5 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Evolution, function, and utilization of major histocompatibility complex polymorphism in autoimmune disease

5 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Genetic influences on neuroimmunologic disease

5 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Multiple sclerosis and its animal models: the role of the major histocompatibility complex and the T cell receptor repertoire

5 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein

5 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis

5 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients

5 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition

5 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis

5 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein

5 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein

5 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice

5 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins

5 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention

5 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

T cell recognition as the target for immune intervention in autoimmune disease

5 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

5 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

T cell specificity for class II (I-A) and the encephalitogenic N-terminal epitope of the autoantigen myelin basic protein

5 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity

5 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Experimental allergic encephalomyelitis mediated by murine encephalitogenic T cell lines specific for myelin proteolipid apoprotein

5 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Determinants of human myelin basic protein that induce encephalitogenic T cells in Lewis rats

5 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype

5 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Expression of a murine polyclonal T cell receptor marker correlates with the use of specific members of the V beta 8 gene segment subfamily

5 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis

5 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Diversity of the class II (I-Ak/I-Ek)-restricted T cell repertoire for influenza hemagglutinin and antigenic drift. Six nonoverlapping epitopes on the HA1 subunit are defined by synthetic peptides.

5 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Correlation of T cell receptor V beta gene family with MHC restriction

5 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy

5 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

The T-cell receptor repertoire and autoimmune diseases

5 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Correlations between T-cell specificity and the structure of the antigen receptor.

5 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

A T cell receptor V beta segment that imparts reactivity to a class II major histocompatibility complex product.

5 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

T cell tolerance by clonal elimination in the thymus

5 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Regions of allelic hypervariability in the murine Aα immune response gene

5 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Sequence analysis and structure-function correlations of murine q, k, u, s, and f haplotype I-A beta cDNA clones

5 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Differences in the repertoire of the Lewis rat T cell response to self and non-self myelin basic proteins

5 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

The V-region disease hypothesis: evidence from autoimmune encephalomyelitis

5 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized

5 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

T cell determinants of myelin basic protein include a unique encephalitogenic I-E-restricted epitope for Lewis rats.

5 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

A Molecular Basis for MHC Class II—Associated Autoimmunity

5 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis

5 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Prevention of experimental allergic encephalitis with in vivo administration of anti I-A antibody. Decreased accumulation of radiolabelled lymph node cells in the central nervous system.

5 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes

5 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Successful treatment of EAE in rhesus monkeys with MHC class II specific monoclonal antibodies

5 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor

5 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Inhibition of experimental autoimmune thyroiditis in mice by anti-I-A antibodies

5 November 2022

52

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Autoimmune T cells: immune recognition of normal and variant peptide epitopes and peptide-based therapy

5 November 2022

53

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination.

5 November 2022

54

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

5 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Lines of T Lymphocytes Induce or Vaccinate Against Autoimmune Arthritis

5 November 2022

56

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis

5 November 2022

58

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides

5 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis

5 November 2022

60

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis

5 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1

5 November 2022

62

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies

5 November 2022

63

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

Residues of the variable region of the T-cell-receptor β-chain that interact with S. aureus toxin superantigens

5 November 2022

64

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60779-8

5 November 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1713016

5 November 2022

1 reference